149 related articles for article (PubMed ID: 18456465)
1. Pharmacokinetics of azithromycin in serum and sinus fluid after administration of extended-release and immediate-release formulations in patients with acute bacterial sinusitis.
Ehnhage A; Rautiainen M; Fang AF; Sanchez SP
Int J Antimicrob Agents; 2008 Jun; 31(6):561-6. PubMed ID: 18456465
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of azithromycin in plasma and sinus mucosal tissue following administration of extended-release or immediate-release formulations in adult patients with chronic rhinosinusitis.
Fang AF; Palmer JN; Chiu AG; Blumer JL; Crownover PH; Campbell MD; Damle BD
Int J Antimicrob Agents; 2009 Jul; 34(1):67-71. PubMed ID: 19307106
[TBL] [Abstract][Full Text] [Related]
3. Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial.
Marple BF; Roberts CS; de Caprariis PJ; Reisman A
Clin Ther; 2007 Dec; 29(12):2690-8. PubMed ID: 18201585
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin.
Lucchi M; Damle B; Fang A; de Caprariis PJ; Mussi A; Sanchez SP; Pasqualetti G; Del Tacca M
J Antimicrob Chemother; 2008 Apr; 61(4):884-91. PubMed ID: 18252692
[TBL] [Abstract][Full Text] [Related]
5. Single-dose extended-release oral azithromycin vs. 3-day azithromycin for the treatment of group A beta-haemolytic streptococcal pharyngitis/tonsillitis in adults and adolescents: a double-blind, double-dummy study.
Jorgensen DM
Clin Microbiol Infect; 2009 Dec; 15(12):1103-10. PubMed ID: 19929975
[TBL] [Abstract][Full Text] [Related]
6. Sinus fluid penetration of oral clarithromycin and azithromycin in patients with acute rhinosinusitis.
Margaritis VK; Ismailos GS; Naxakis SS; Mastronikolis NS; Goumas PD
Am J Rhinol; 2007; 21(5):574-8. PubMed ID: 17999793
[TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen.
Liu P; Allaudeen H; Chandra R; Phillips K; Jungnik A; Breen JD; Sharma A
Antimicrob Agents Chemother; 2007 Jan; 51(1):103-9. PubMed ID: 17060516
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of azithromycin after i.v. and i.m. administration to sheep.
Cárceles CM; Font A; Escudero E; Espuny A; Marín P; Fernández-Varón E
J Vet Pharmacol Ther; 2005 Oct; 28(5):475-9. PubMed ID: 16207311
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
10. Azithromycin extended-release (Zmax) for sinusitis and pneumonia.
Obstet Gynecol; 2006 Jan; 107(1):180-2. PubMed ID: 16394059
[No Abstract] [Full Text] [Related]
11. Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.
Girard D; Finegan SM; Dunne MW; Lame ME
J Antimicrob Chemother; 2005 Aug; 56(2):365-71. PubMed ID: 16002421
[TBL] [Abstract][Full Text] [Related]
12. Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers.
Torkildsen G; O'Brien TP
Clin Ther; 2008 Nov; 30(11):2005-14. PubMed ID: 19108788
[TBL] [Abstract][Full Text] [Related]
13. Penetration of azithromycin in experimental pleural empyema fluid.
Saroglou M; Ismailos G; Tryfon S; Liapakis I; Papalois A; Bouros D
Eur J Pharmacol; 2010 Jan; 626(2-3):271-5. PubMed ID: 19854169
[TBL] [Abstract][Full Text] [Related]
14. A survey on diarrhea and convenience of intake associated with a single-dose extended release formulation of azithromycin.
Okayasu S; Matsuura K; Kondoh Y; Tsuruta E; Takashima E; Suzuki M; Nagai T; Yasuda K; Itoh Y
Pharmazie; 2011 Mar; 66(3):226-9. PubMed ID: 21553656
[TBL] [Abstract][Full Text] [Related]
15. Comparison of azithromycin pharmacokinetics following single oral doses of extended-release and immediate-release formulations in children with acute otitis media.
Liu P; Fang AF; LaBadie RR; Crownover PH; Arguedas AG
Antimicrob Agents Chemother; 2011 Nov; 55(11):5022-6. PubMed ID: 21859932
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and tissue tolerance of azithromycin after intramuscular administration to rabbits.
Escudero E; Fernández-Varón E; Marín P; Espuny A; Nájera MD; Cárceles CM
Res Vet Sci; 2006 Dec; 81(3):366-72. PubMed ID: 16530237
[TBL] [Abstract][Full Text] [Related]
17. Azithromycin extended release: a review of its use in the treatment of acute bacterial sinusitis and community-acquired pneumonia in the US.
Swainston Harrison T; Keam SJ
Drugs; 2007; 67(5):773-92. PubMed ID: 17385947
[TBL] [Abstract][Full Text] [Related]
18. Azithromycin concentrations in sinus fluid and mucosa after oral administration.
Karma P; Pukander J; Penttilä M
Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):856-9. PubMed ID: 1662632
[TBL] [Abstract][Full Text] [Related]
19. [Azithromycin: tissue pharmacology].
Bergogne-Bérézin E
Pathol Biol (Paris); 1995 Jun; 43(6):498-504. PubMed ID: 8539071
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of azithromycin in trachoma patients: serum and tear levels.
Karcioglu ZA; El-Yazigi A; Jabak MH; Choudhury AH; Ahmed WS
Ophthalmology; 1998 Apr; 105(4):658-61. PubMed ID: 9544640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
